日科化学
(300214)
| 流通市值：31.44亿 | | | 总市值：36.22亿 |
| 流通股本：4.04亿 | | | 总股本：4.65亿 |
| 报告期 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 2,826,848,472.82 | 1,957,070,237.88 | 931,593,350.81 | 3,518,393,513.02 |
| 营业收入 | 2,826,848,472.82 | 1,957,070,237.88 | 931,593,350.81 | 3,518,393,513.02 |
| 二、营业总成本 | 2,859,520,083.82 | 1,981,280,459.49 | 951,530,143.58 | 3,543,701,641.22 |
| 营业成本 | 2,695,190,262.31 | 1,876,056,133.74 | 888,955,004.77 | 3,327,252,433.83 |
| 税金及附加 | 18,809,805.78 | 13,234,697.8 | 6,246,862.04 | 23,343,245.77 |
| 销售费用 | 26,572,838.4 | 17,739,150.98 | 8,973,054.74 | 36,446,004.39 |
| 管理费用 | 60,614,841.47 | 38,985,355.49 | 26,996,151.36 | 86,000,397.3 |
| 研发费用 | 27,742,565.64 | 16,445,070.05 | 10,497,948.64 | 40,361,367.62 |
| 财务费用 | 30,589,770.22 | 18,820,051.43 | 9,861,122.03 | 30,298,192.31 |
| 其中:利息费用 | 32,862,077.44 | 23,419,169.37 | 11,597,262.49 | 35,816,983.52 |
| 其中:利息收入 | 1,183,248.09 | 859,579.68 | 552,012.9 | 1,731,486.47 |
| 三、其他经营收益 | | | | |
| 加:公允价值变动收益 | - | 0 | 0 | 0 |
| 加:投资收益 | 1,850,016.24 | 1,387,817.52 | 603,331.55 | 3,839,107.06 |
| 净敞口套期收益 | - | 0 | 0 | 0 |
| 资产处置收益 | 4,276,463.95 | 130,838.57 | 0 | -237,640.19 |
| 资产减值损失(新) | 17,604,733.28 | 14,213,209.76 | 8,748,036.38 | -53,591,107.99 |
| 信用减值损失(新) | -2,124,988.45 | -3,592,818.26 | -3,452,999.7 | -20,746,604.99 |
| 其他收益 | 7,567,707.11 | 4,906,710.53 | 2,587,110.4 | 6,437,819.23 |
| 四、营业利润 | -3,497,678.87 | -7,164,463.49 | -11,451,314.14 | -89,606,555.08 |
| 加:营业外收入 | 45,593.12 | 73,180.59 | 33,451.52 | 821,545.33 |
| 减:营业外支出 | 1,614,767.83 | 309,609.12 | 99,241.82 | 2,200,376.32 |
| 五、利润总额 | -5,066,853.58 | -7,400,892.02 | -11,517,104.44 | -90,985,386.07 |
| 减:所得税费用 | -5,578,181.64 | -5,040,068.95 | -946,358.35 | -23,464,577.11 |
| 六、净利润 | 511,328.06 | -2,360,823.07 | -10,570,746.09 | -67,520,808.96 |
| (一)按经营持续性分类 | | | | |
| 持续经营净利润 | 511,328.06 | -2,360,823.07 | -10,570,746.09 | -67,520,808.96 |
| (二)按所有权归属分类 | | | | |
| 归属于母公司股东的净利润 | 4,016,187.89 | 1,156,070.76 | -8,634,199.21 | -68,161,215.83 |
| 少数股东损益 | -3,504,859.83 | -3,516,893.83 | -1,936,546.88 | 640,406.87 |
| 扣除非经常损益后的净利润 | 599,032.92 | -123,646.98 | -11,026,995.1 | -70,267,436.61 |
| 七、每股收益 | | | | |
| (一)基本每股收益 | 0.01 | 0 | -0.02 | -0.15 |
| (二)稀释每股收益 | 0.01 | 0 | -0.02 | -0.15 |
| 九、综合收益总额 | 511,328.06 | -2,360,823.07 | -10,570,746.09 | -67,520,808.96 |
| 归属于母公司股东的综合收益总额 | 4,016,187.89 | 1,156,070.76 | -8,634,199.21 | -68,161,215.83 |
| 归属于少数股东的综合收益总额 | -3,504,859.83 | -3,516,893.83 | -1,936,546.88 | 640,406.87 |
| 公告日期 | 2025-10-23 | 2025-08-26 | 2025-04-26 | 2025-04-18 |
| 审计意见(境内) | | | | 标准无保留意见 |